Myeloblasts from Down Syndrome Children with Acute Myeloid Leukemia have Increased In Vitro Sensitivity to Cytarabine and Daunorubicin
Taub JW, Stout ML, Becton DL. Myeloblasts from Down Syndrome Children with Acute Myeloid Leukemia have Increased In Vitro Sensitivity to Cytarabine and Daunorubicin. Leukemia. 1997; 11(9):1594-95.